Zimmer Biomet Q1 EPS Forecast Reduced by Zacks Research
Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...
Zimmer Biomet Holdings, Inc.: Zimmer Biomet Receives FDA Clearance for Persona Revision SoluTion Femur
A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ...
Le Lézard7d
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTiontm Femur
Zimmer Biomet Holdings, Inc. , a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTiontm Femur, a revision knee ...
Zimmer Biomet Holdings, Inc.: Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kristen Cardillo as ...
TMCnet8d
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of ...
Sokolove Law14d
Zimmer Biomet Hip Replacement Lawsuit
Zimmer Biomet CPT ® Hip System implants may put patients at an increased risk of suffering a broken thigh bone near the device. In some cases, patients may even need to undergo corrective surgery. At ...
TMCnet14d
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
WARSAW, Ind., Feb. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 27 th Annual ...
Investing15d
Zimmer Biomet names Jehanzeb Noor as new strategy and innovation chief
WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a notable player in the medical technology industry with a market capitalization of $20.89 billion and impressive gross profit margins of 71.6%, ...
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as Senior Vice President, Chief Strategy, Innovation and ...
Nasdaq15d
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
WARSAW, Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as ...
Investing16d
Zimmer Biomet names Jehanzeb Noor as new strategy and innovation chief
WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a notable player in the medical technology industry with a market capitalization of $20.89 billion and impressive gross profit margins of 71 ...